In The News: School of Integrated Health Sciences
The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment and show the agency's willingness to approve badly needed medicines based on less than definitive data.
The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment and show the agency's willingness to approve badly needed medicines based on less than definitive data.
The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer's disease research, two new studies show.
The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer's disease research, two new studies show.
Two articles published by Alzheimer's & Dementia: Translational Research & Clinical Interventions show substantial changes in the focus and funding of clinical trials for Alzheimer's disease therapies. The newly published articles throw a greater spotlight on a decision—now before the U.S. Food and Drug Administration (FDA)—that would potentially bring a new drug therapy to Alzheimer's patients for the first time in nearly 20 years.
Nonprofit organizations and public agencies have picked up the slack and are funding increased numbers of clinical trials to drive growth and innovation in an area where there is pressing unmet medical need.
Epsom salt is commonly dissolved in baths and used as a home remedy because it is rumored that absorbing magnesium through the skin can provide numerous health benefits.
As the Black Death, also known as the Black Plague, ravaged Europe and Asia in the mid-1300s, people became increasingly desperate for any iota of respite. Some tried blood-letting. Others opted for rubbing onions—or, in some cases, a chopped snake—directly onto their infected boils.
In the US, about 6.2 million people have Alzheimer's disease. ҳ| 鶹ýӳ 70% experience agitation — extreme emotional distress that can manifest as resisting care, shouting, or becoming physically violent — and 40% have symptoms severe enough to require treatment, Dr. Jeffrey Cummings told Insider. But there isn't a single approved drug to treat agitation in people with Alzheimer's.
Dr. Kara Radzak interviews Dr. Sandy Shultz, Dr. Lindsey Lepley, and Dr. Shelby Baez about the work investigating ACL injury risk and rehabilitation strategies for patients with ACL reconstruction. This interview is accompanying the release of a special issue of the Journal of Athletic Training women who are scholars in athletic training research.
The theme song of an ’80s sitcom goes, “You take the good, you take the bad/You take them both and there you have/The facts of life.” The same can be said of our gut microbiome, the complex system—comprising 300 to 500 species of good and bad bacteria—that affects not just our digestive system but also has links to mental health, autoimmune diseases, endocrine disorders, cancer and more.
The pandemic has done a number on our stomachs. We’re mostly stuck at home—whether working remotely or just staying safe in quarantine. And it’s too easy to just snack all day.